FFCP PHASE1:Mm9::chr2:134314492..134314494,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |EntrezGene=NA | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |association_with_transcript=NA | ||
|cluster_id=chr2:134314492..134314494,- | |||
|description=CAGE_peak_at_chr2:134314492..134314494,- | |description=CAGE_peak_at_chr2:134314492..134314494,- | ||
|id=chr2:134314492..134314494,- | |id=chr2:134314492..134314494,- | ||
|ontology_enrichment_celltype=CL:0000355!5.14e-18!9 | |ontology_enrichment_celltype=CL:0000355!5.14e-18!9 | ||
|ontology_enrichment_celltype_v019_2=CL:0000355,5.14e-18,9 | |||
|ontology_enrichment_disease=DOID:0060100!5.51e-52!3;DOID:4045!5.51e-52!3;DOID:0050686!1.55e-26!6 | |ontology_enrichment_disease=DOID:0060100!5.51e-52!3;DOID:4045!5.51e-52!3;DOID:0050686!1.55e-26!6 | ||
|ontology_enrichment_disease_v019_2=DOID:0060100,5.51e-52,3;DOID:4045,5.51e-52,3;DOID:0050686,1.55e-26,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!5.14e-18!9;UBERON:0002036!5.14e-18!9;UBERON:0002385!5.14e-18!9;UBERON:0000486!5.14e-18!9;UBERON:0001015!5.14e-18!9;UBERON:0004290!5.14e-18!9;UBERON:0003082!5.14e-18!9;UBERON:0000383!2.64e-16!10;UBERON:0002329!6.63e-15!11;UBERON:0003077!6.63e-15!11;UBERON:0003059!6.63e-15!11;UBERON:0007282!6.63e-15!11;UBERON:0009618!6.63e-15!11;UBERON:0007285!6.63e-15!11;UBERON:0000914!6.13e-10!17 | |ontology_enrichment_uberon=UBERON:0001134!5.14e-18!9;UBERON:0002036!5.14e-18!9;UBERON:0002385!5.14e-18!9;UBERON:0000486!5.14e-18!9;UBERON:0001015!5.14e-18!9;UBERON:0004290!5.14e-18!9;UBERON:0003082!5.14e-18!9;UBERON:0000383!2.64e-16!10;UBERON:0002329!6.63e-15!11;UBERON:0003077!6.63e-15!11;UBERON:0003059!6.63e-15!11;UBERON:0007282!6.63e-15!11;UBERON:0009618!6.63e-15!11;UBERON:0007285!6.63e-15!11;UBERON:0000914!6.13e-10!17 | ||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,5.14e-18,9;UBERON:0002036,5.14e-18,9;UBERON:0002385,5.14e-18,9;UBERON:0000486,5.14e-18,9;UBERON:0007503,5.14e-18,9;UBERON:0001015,5.14e-18,9;UBERON:0002329,5.14e-18,9;UBERON:0003082,5.14e-18,9;UBERON:0003059,5.14e-18,9;UBERON:0007282,5.14e-18,9;UBERON:0004290,5.14e-18,9;UBERON:0009618,5.14e-18,9;UBERON:0000383,2.64e-16,10;UBERON:0007524,6.63e-15,11;UBERON:0003077,6.63e-15,11;UBERON:0007285,6.63e-15,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.76678467663217,1.5626706890476,2.09409497589519,9.99993529652724,4.09827290975067,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.76678467663217,1.5626706890476,2.09409497589519,9.99993529652724,4.09827290975067,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr2:134314492..134314494,- | |short_description=p@chr2:134314492..134314494,- | ||
}} | }} |
Latest revision as of 03:05, 4 August 2015
Short description: | p@chr2:134314492..134314494, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr2:134314492..134314494, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 5.14e-18 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 5.14e-18 | 9 |
striated muscle tissue | 5.14e-18 | 9 |
muscle tissue | 5.14e-18 | 9 |
multilaminar epithelium | 5.14e-18 | 9 |
epithelial vesicle | 5.14e-18 | 9 |
musculature | 5.14e-18 | 9 |
somite | 5.14e-18 | 9 |
myotome | 5.14e-18 | 9 |
presomitic mesoderm | 5.14e-18 | 9 |
presumptive segmental plate | 5.14e-18 | 9 |
dermomyotome | 5.14e-18 | 9 |
trunk paraxial mesoderm | 5.14e-18 | 9 |
musculature of body | 2.64e-16 | 10 |
dense mesenchyme tissue | 6.63e-15 | 11 |
paraxial mesoderm | 6.63e-15 | 11 |
presumptive paraxial mesoderm | 6.63e-15 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 5.51e-52 | 3 |
muscle cancer | 5.51e-52 | 3 |
organ system cancer | 1.55e-26 | 6 |